1286546-19-7

Upstream product

• 1193-02-8 4-aminotiophenol 
• 78-88-6 2,3-Dichloroprop-1-ene 
• 1126-81-4 4-acetamidothiophenol 

Downstream Products

• 1415786-91-2 2-methyl-N,N-diphenylbenzo[b]thiophen-5-amine 
• 1415786-94-5 4-bromo-N, N-diphenyl-2-methylbenzo[b]thiophen-5-amine 
• 1428647-23-7 C₂₆H₁₆F₇NS 
• 1428647-24-8 C₄₇H₃₂F₆N₂S₂ 

Relevant academic research and scientific papers

Synthesis, fine structure of 19F NMR and fluorescence of novel amorphous TPA derivatives having perfluorinated cyclopentenyl and benzo[b]thiophene unit

Three novel triphenylamine (TPA) derivatives having perfluorinated cyclopentenyl and benzo[b]thiophene unit are obtained from 4-bromo-N,N-diphenyl- 2-methylbenzo[b]thiophen-5-amine. The new compounds are expected to find their use in thin film devices as charge transport materials and host organic light-emitting materials. It is found that the new compounds show relatively strong fluorescence either in solution or in solid state, and are amorphous due to a special conformation which is elucidated by the fine structure of 19F NMR. Molecular structure and properties of these compounds is characterized by 1H NMR, 13C NMR (broadband decoupled), ESI-HRMS, elemental analysis and thermal analysis (DSC). Fluorescent quantum yield in solution is measured using 9,10-diphenylanthrancene (DPA) as standard fluorescent substance.

HETEROARYL COMPOUNDS AS INHIBITORS OF PROGRAMMED NECROSIS PATHWAY, COMPOSITION AND METHOD USING THE SAME

The present disclosure provides heteroaryl compounds of Formula (I), processes for their preparation, pharmaceutical compositions containing them, and their use in the treatment of diseases and disorders, arising from or related to the programmed necrosis pathway.